NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
$4.49
+1.58%
$115.0M
No data for this timeframe.
Vol
Market Cap$115.0M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (89%)
Inst. Holders4 funds
Inst. Value$3.4M
Inst. Activity2 buys / 0 sells
Insider Activity11B / 0S
Insider Net $$425.2K
SEC Reports15
Press Releases1
Recent Activity
May 29, 2026
other
The Next Great AI Revolution May Be Drug Delivery
NeOnc (NASDAQ:NTHI) is developing therapies and delivery technologies targeting aggressive brain can
May 18, 2026
SEC
NeOnc reported Q1 2026 net loss of $8.8M (-$0.38/sh) vs consensus -$0.30, a 26.7% miss, but this is typical for pre-reve
8-K — Impact 5/10
May 18, 2026
SEC
NeOnc reported Q1 2026 EPS of -$0.38, a 245.5% miss vs consensus of -$0.11, with zero revenue. The net loss improved YoY
PRESS-RELEASE — Impact 6/10
May 5, 2026
SEC
NeOnc Technologies Holdings filed Amendment No. 1 to its 2025 10-K solely to add Part III information (Items 10-14) that
10-K/A — Impact 3/10
May 1, 2026
Insider
Heshmatpour Amir F bought 10,000 shares
President @ $4.16 ($41.6K)
Apr 28, 2026
Insider
Heshmatpour Amir F bought 10,000 shares
President @ $4.52 ($45.2K)
Apr 23, 2026
Insider
Heshmatpour Amir F bought 10,000 shares
President @ $4.90 ($49.0K)
Inst.
VANGUARD GROUP INC — ADD
181,029 shares ($1.5M)
Price Targets
$16.00
+262.0% upside
Strong Buy
Current $4.42
Low $13.00
Median $15.00
High $20.00
3 analysts
$13.00
$20.00
Analyst Ratings
3Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 26, 2026 | BTIG | REITERATE | Buy → Buy |
| May 19, 2026 | Alliance Global Partners | INITIATE | Buy |
| May 18, 2026 | Maxim Group | INITIATE | Buy |
| Apr 24, 2026 | BTIG | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.17 ▲ +30.6% | $-0.26 — $-0.10 | 3 | |
| Next Q | $-0.17 ▲ +27.5% | $-0.26 — $-0.08 | 3 | |
| Current FY | $-0.85 ▲ +15.4% | $-1.16 — $-0.65 | 73% YoY | 3 |
| Next FY | $-0.75 ▼ -42.1% | $-1.02 — $-0.49 | 11% YoY | 3 |
Latest Reports
MIXED
8-K
5/10
NeOnc reported Q1 2026 net loss of $8.8M (-$0.38/sh) vs consensus -$0.30, a 26.7% miss, but this is typical for pre-reve
May 18, 2026
BEARISH
PRESS-RELEASE
6/10
NeOnc reported Q1 2026 EPS of -$0.38, a 245.5% miss vs consensus of -$0.11, with zero revenue. The net loss improved YoY
May 18, 2026
MIXED
Press
6/10
NeOnc Technologies reported Q4 2025 earnings with a widened net loss of $62.1M, driven by higher G&A and R&D expenses, w
Apr 1, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BANK OF AMERICA CORP | $1.9M | NEW |
| VANGUARD GROUP INC | $1.5M | ADD |
| MORGAN STANLEY | $67.8K | NEW |
| WELLS FARGO & COMPANY/MN | $12.4K | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 1, 2026 | Heshmatpour Amir | BUY | $41.6K |
| Apr 28, 2026 | Heshmatpour Amir | BUY | $45.2K |
| Apr 23, 2026 | Heshmatpour Amir | BUY | $49.0K |
| Apr 23, 2026 | Neman-Ebrahim Yousha | BUY | $2.4K |
| Apr 10, 2026 | Heshmatpour Amir | BUY | $48.9K |
4 institutional holders with $3.4M total value (415,021 shares) as of 2025-Q4. Top holders: BANK, VANGUARD, MORGAN. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 224,288 | $1.9M | 54.0% | NEW |
| 2 | VANGUARD GROUP INC | 181,029 | $1.5M | 43.6% | ADD +28.5% |
| 3 | MORGAN STANLEY | 8,204 | $67.8K | 2.0% | NEW |
| 4 | WELLS FARGO & COMPANY/MN | 1,500 | $12.4K | 0.4% | NEW |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | ADD | 140,911 | 181,029 | +28.5% | $1.5M | 2025-Q4 |
| MORGAN STANLEY | NEW | — | 8,204 | — | $67.8K | 2025-Q4 |
| VANGUARD GROUP INC | NEW | — | 140,911 | — | $1.3M | 2025-Q3 |
| UBS Group AG | TRIM | 9,444 | 3,113 | -67.0% | $28.3K | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | NEW | — | 1,500 | — | $13.6K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | NEW | — | 224,279 | — | $800.7K | 2025-Q2 |
| UBS Group AG | NEW | — | 9,444 | — | $33.7K | 2025-Q2 |
4 unique insiders with 11 transactions. Net insider value: $425.2K ($425.2K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 1, 2026 | Heshmatpour Amir F | President | BUY | 10,000 | $4.16 | $41.6K |
| Apr 28, 2026 | Heshmatpour Amir F | President | BUY | 10,000 | $4.52 | $45.2K |
| Apr 23, 2026 | Heshmatpour Amir F | President | BUY | 10,000 | $4.90 | $49.0K |
| Apr 23, 2026 | Neman-Ebrahim Yousha | Chief Clinical Officer | BUY | 500 | $4.88 | $2.4K |
| Apr 10, 2026 | Heshmatpour Amir F | President | BUY | 10,000 | $4.90 | $48.9K |
| Apr 9, 2026 | Heshmatpour Amir F | President | BUY | 5,000 | $5.19 | $26.0K |
| Apr 9, 2026 | SUH, DAVID JR. | Chief Accounting Officer | BUY | 200 | $5.00 | $1.0K |
| Apr 8, 2026 | Heshmatpour Amir F | President | BUY | 10,000 | $5.61 | $56.1K |
| Apr 6, 2026 | Heshmatpour Amir F | President | BUY | 5,000 | $6.32 | $31.6K |
| Apr 2, 2026 | Heshmatpour Amir F | President | BUY | 20,000 | $6.09 | $121.8K |
| Mar 1, 2026 | SUH, DAVID JR. | Chief Accounting Officer | A | 111,666 | $0.00 | $0.00 |
| Mar 1, 2026 | SUH, DAVID JR. | Chief Accounting Officer | A | 58,334 | $0.00 | $0.00 |
| Apr 15, 2025 | GARNETT KEITHLY | CFO | BUY | 300 | $5.38 | $1.6K |
15 SEC filing reports analyzed. Sentiment: 1 bullish, 6 bearish, 2 mixed, 6 neutral. Avg impact: 5.2/10.
MIXED
8-K
5/10
NeOnc reported Q1 2026 net loss of $8.8M (-$0.38/sh) vs consensus -$0.30, a 26.7% miss, but this is
May 18, 2026
BEARISH
PRESS-RELEASE
6/10
NeOnc reported Q1 2026 EPS of -$0.38, a 245.5% miss vs consensus of -$0.11, with zero revenue. The n
May 18, 2026
NEUTRAL
10-K/A
3/10
NeOnc Technologies Holdings filed Amendment No. 1 to its 2025 10-K solely to add Part III informatio
May 5, 2026
NEUTRAL
CLUSTER
2/10
Two NEONC insiders, including the President, made small open-market purchases totaling ~$48K over th
Apr 28, 2026
MIXED
CLUSTER
6/10
Two C-suite executives at NEONC Technologies Holdings purchased shares in the open market, totaling
Apr 24, 2026
BEARISH
8-K
7/10
NEONC Technologies Holdings has entered into a fourth securities purchase agreement, raising $2 mill
Apr 24, 2026
BEARISH
8-K
8/10
NEONC Technologies reported a significant net loss of $62.1 million for Q4 2025, driven by increased
Apr 21, 2026
NEUTRAL
EFFECT
4/10
NEONC Technologies Holdings, Inc. (NTHI) has had its S-3 shelf registration become effective, allowi
Apr 17, 2026
BULLISH
8-K
7/10
NeOnc Technologies CEO purchased $300,000 of stock, signaling confidence ahead of near-term clinical
Apr 16, 2026
BEARISH
424B5
7/10
NEONC Technologies Holdings has filed a 424B5 prospectus to register the resale of 680,558 shares of
Apr 16, 2026
NEUTRAL
CLUSTER
3/10
Two corporate insiders at NEONC Technologies Holdings (NTHI) purchased shares in open-market transac
Apr 13, 2026
BEARISH
8-K
7/10
NeOnc Technologies Holdings (NTHI) has entered into an at-the-market (ATM) equity distribution agree
Apr 10, 2026
BEARISH
424B5
7/10
NEONC Technologies Holdings (NTHI) has launched an at-the-market (ATM) equity offering of up to $75
Apr 10, 2026
NEUTRAL
S-3
3/10
NEONC Technologies Holdings, Inc. (NTHI) has filed an S-3 shelf registration, enabling the company t
Apr 2, 2026
NEUTRAL
8-K
3/10
NeOnc Technologies Holdings, Inc. (NTHI) appointed David Choi as Chief Accounting Officer on March 1
Mar 17, 2026
Current analyst consensus: Strong Buy (89% buy). Based on 9 analysts: 3 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$16.00 mean target
+262.0% upside
Strong Buy (1.33)
$13.00 Low
$20.00 High
| Metric | Value |
|---|---|
| Current Price | $4.42 |
| Target Low | $13.00 |
| Target Mean | $16.00 |
| Target Median | $15.00 |
| Target High | $20.00 |
| # Analysts | 3 |
| Recommendation | Strong Buy (1.33) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.17 | $-0.26 | $-0.10 | — | +30.6% | 1↑ 0↓ | $0.0B | — | 3 |
| Next Q 2026-09-30 |
$-0.17 | $-0.26 | $-0.08 | — | +27.5% | 1↑ 0↓ | $0.0B | — | 3 |
| Current FY 2026-12-31 |
$-0.85 | $-1.16 | $-0.65 | 73.4% | +15.4% | 0↑ 1↓ | $0.0B | -100.0% | 3 |
| Next FY 2027-12-31 |
$-0.75 | $-1.02 | $-0.49 | 11.4% | -42.1% | 1↑ 0↓ | $0.0B | 0.0% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.167 | |
| 7d ago | $-0.207 | +0.040 |
| 30d ago | $-0.240 | +0.073 |
| 60d ago | $-0.370 | +0.203 |
| 90d ago | $-0.370 | +0.203 |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 3 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 26, 2026 | BTIG | REITERATE | Buy | Buy |
| May 19, 2026 | Alliance Global Partners | INITIATE | — | Buy |
| May 18, 2026 | Maxim Group | INITIATE | — | Buy |
| Apr 24, 2026 | BTIG | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| May 1, 2026 | 3 | 3 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 29, 2026
other
The Next Great AI Revolution May Be Drug Delivery
NeOnc (NASDAQ:NTHI) is developing therapies and delivery technologies targeting aggressive brain cancers and CNS-related conditions, and could be part
May 19, 2026
other
NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones
Wall St analysts are rating NeOnc Technologies (NASDAQ:NTHI) a “Buy”, as institutional investors and company insiders are buying
May 18, 2026
earnings
NeOnc Provides Business Update and Reports Q1 2026 Financial Results
<p>CALABASAS, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage
May 7, 2026
other
Biotech’s Next Wave May Already be in Motion
Insider conviction, late-stage clinical wins, and platform technologies are converging to reshape biotech/pharma valuations and patient outcomes.
May 7, 2026
earnings_calendar
NTHI Q1 2026 Earnings Scheduled — 2026-05-07
May 6, 2026
other
Where Executives Are Doubling Down on Their Companies’ Fortunes
Insiders are buying shares of $NTHI, $RIVN, $SRAD, $NWBI, and $FGBI
Apr 1, 2026
earnings
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
<p align="left">CALABASAS, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a
Mar 13, 2026
other
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
<p>CALABASAS, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a multi-Phase
Mar 2, 2026
earnings_calendar
NTHI Q4 2025 Earnings Scheduled — 2026-03-02